
STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.

An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations. Now seven labs will get sizable grants.

The lawn and garden care brand’s broader use of Kinaxis technology aims to unify planning, decision-making and execution into a single platform.
© 2026 Industry Events Worldwide. All rights reserved.
One short email. Top stories from the trade shows, conferences and summits shaping business worldwide. No fluff, no spam, unsubscribe anytime.